image
Lexicon Pharmaceuticals, Inc. LXRX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.9752
-8 %
$ 353 M
Market Cap
-1.27
P/E
BALANCE SHEET
229 M ASSETS
18.08%
Growth Rates
1Year 18.08%
3Years 4.03%
5Years -4.19%
7Years -9.89%
10Years -1.77%
136 M LIABILITIES
76.64%
Growth Rates
1Year 76.64%
3Years 42.19%
5Years -15.18%
7Years -11.41%
10Years 2.74%
93.1 M EQUITY
105.86%
Growth Rates
1Year 105.86%
3Years -15.87%
5Years 15.59%
7Years -7.23%
10Years 7.66%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Lexicon Pharmaceuticals, Inc.
image
Current Assets 177 M
Cash & Short-Term Investments 170 M
Receivables 1.01 M
Other Current Assets 5.51 M
Non-Current Assets 52.9 M
Long-Term Investments 0
PP&E 7.51 M
Other Non-Current Assets 45.4 M
Current Liabilities 31.5 M
Accounts Payable 14.4 M
Short-Term Debt 1.29 M
Other Current Liabilities 15.9 M
Non-Current Liabilities 105 M
Long-Term Debt 105 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999
ASSETS
Cash & Cash Equivalents 22.5 46.3 64.1 126.3 36.1 160.1 310.8 346.5 521.4 339.3 129.1 223.2 281.7 47.2 100.6 85.9 22.9 30.2 22.0 14.6 81.9 39.4 23.0 37.8 2.0
Short Term Investments 147.6 92.0 22.7 26.0 235.5 79.7 249.1 299.9 318.4 202.1 91.6 192.8 95.4 163.9 62.0 17.2 235.8 49.8 77.7 72.9 22.1 54.2 133.4 164.9 7.1
Receivables 1.0 28 K 14 K 0.4 56.5 5.9 4.8 7.5 0.9 1.0 0.8 1.4 0.3 0.7 0.8 0.6 1.8 1.2 2.6 6.4 6.6 5.1 4.5 2.8 3.4
Inventory 0.4 0 0 1 4.2 4.7 1.9 0 1 4.8 1 0 (4.1) 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 5.1 2.5 4.3 10.1 10.6 5.3 8.9 7.8 20.3 28.6 9.3 12.7 7.5 5.8 6.4 5.5 4.1 8.7 3.7 4.8 60.9 34.4 12.1 0.5 100 K
Total Current Assets 176.5 140.9 88.9 157.7 337.8 173.3 322.0 357.9 532.4 369.0 134.6 230.9 281.7 214.7 169.7 109.2 264.6 85.6 106.0 98.7 171.5 133.1 166.4 206.0 12.6
PP&E 7.5 2.1 1.2 0.3 14.0 15.9 17.7 19.4 21.2 1.1 41.4 42.6 46.4 53.4 58.8 65.1 70.8 78.2 85.3 84.6 83.7 37.4 26.7 14.5 9.4
Intangible Assets 0 0 0 0 19.7 50.1 51.9 53.4 53.4 53.4 53.6 53.6 53.6 53.6 0 0 0 0 26.4 27.6 28.8 30.0 5.4 0 0
Goodwill 44.5 44.5 44.5 44.5 44.5 44.5 44.5 44.5 44.5 44.5 44.5 44.5 44.5 44.5 25.8 25.8 25.8 25.8 0 0 0 0 25.8 0 0
Long Term Investments 0 0 0 0 (4.1) (4.5) (4.9) (468.4) (413.6) 0 0 0 0 0 0 55.7 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.8 6.8 2.3 1.2 1.7 0.3 0.4 0.5 3.3 3.4 0.1 0.1 4.3 0.6 3.5 61.5 8.0 0.7 1.0 1.0 0.2 1.2 15.6 0.2 0.3
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 229.4 194.3 136.9 203.8 417.7 284.1 436.5 475.6 654.8 471.4 274.2 371.8 430.5 366.9 257.8 261.5 369.3 190.3 218.7 212.0 284.2 201.8 240.0 220.7 22.3
LIABILITIES
Accounts Payable 14.4 10.4 9.2 5.5 12.2 12.1 38.8 52.9 19.7 13.1 9.7 7.7 6.0 3.2 5.9 7.9 7.3 6.5 6.9 7.6 5.9 4.4 3.2 2.5 1.2
Short Term Debt 1.3 1.3 1.1 12.2 11.6 (14.4) 2.1 (15.8) (22.8) 10.0 (6.0) (7.3) 1.4 1.1 38.5 1.0 0.9 0.8 4.8 4.7 0 0 0 1.0 9.4
Other Current Liabilities 15.9 11.5 11.9 29.1 41.6 20.2 12.5 32.1 24.8 10.1 7.7 8.9 13.8 6.3 5.6 6.6 9.1 7.3 6.8 6.9 4.8 4.2 5.0 7.7 8 K
Total Current Liabilities 31.5 23.2 22.1 46.8 65.3 36.8 124.1 164.6 123.0 45.0 19.3 18.3 24.9 10.8 51.0 21.2 35.3 46.0 57.5 38.7 31.8 21.3 18.8 11.2 10.6
Long Term Debt 104.8 54.0 1.2 0.6 235.3 243.9 231.6 85.2 101.0 87.5 20.2 21.9 23.5 27.3 28.5 29.5 30.5 31.4 32.2 32.9 56.3 4.0 0 1.8 3.6
Deferred Tax Income 0 0 0 0 4.1 6.0 6.0 18.7 18.7 18.7 18.7 18.7 18.7 18.7 (39.4) (14.2) (16.1) (26.7) 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0.2 0.3 0.8 14.4 23.5 32.4 32.3 55.1 48.8 0.6 0.8 0.8 0.7 0.7 18.7 29.9 6.6 2.8 0 100 K
Total Liabilities 136.3 77.2 23.3 47.4 300.6 310.5 384.4 318.2 369.0 187.4 104.0 105.1 132.9 119.9 94.3 65.7 82.7 104.8 132.9 90.4 118.0 31.9 21.6 13.1 14.1
EQUITY
Common Stock 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.5 0.5 0.5 0.3 0.2 0.1 0.1 78 K 64 K 63 K 63 K 52 K 52 K 48.3 K 0
Retained Earnings (1 766.8) (1 589.7) (1 487.8) (1 400.0) (1 341.4) (1 471.6) (1 381.4) (1 250.4) (1 108.9) (1 104.3) (1 004.0) (899.8) (789.6) (673.4) (570.2) (487.4) (410.5) (351.7) (297.4) (261.1) (213.9) (149.7) (90.1) (54.9) (28.9)
Other Accumulative Comprehensive Income/Loss 31 K (0.4) 10 K 6 K 84 K 12 K (0.2) (0.2) (0.2) 63 K 2 K 23 K 21 K 5 K (75.8) 0 4 K 16 K 54 K 20 K (0.9) (11.1) (22.7) (33.6) (0.9)
Total Equity 93.1 (1 589.7) (1 487.8) 156.4 (1 341.4) (1 471.6) 52.1 157.4 285.9 284.0 (1 004.0) 266.7 297.6 247.0 163.5 195.8 286.6 85.5 85.8 121.6 166.2 169.9 218.4 207.6 8.2
Total Liabilities and Equity 229.4 (1 512.5) (1 464.5) 203.8 (1 040.8) (1 161.0) 436.5 475.6 654.8 471.4 (900.0) 371.8 430.5 366.9 257.8 261.5 369.3 190.3 218.7 212.0 284.2 201.8 240.0 220.7 22.3
SHARES OUTSTANDING
Common Shares Outstanding 221.1 165.7 145.7 110.8 106.2 105.7 105.1 103.9 103.6 76.3 73.3 70.0 48.7 43.3 20.8 19.5 14.3 9.6 9.1 9.0 8.1 7.5 7.2 5.9 3.5